Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP869501.RAOsv8x0wsnv79N48g0SZNgPnjY-KX3QsaEyg2TcszTw0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP869501.RAOsv8x0wsnv79N48g0SZNgPnjY-KX3QsaEyg2TcszTw0130_assertion type Assertion NP869501.RAOsv8x0wsnv79N48g0SZNgPnjY-KX3QsaEyg2TcszTw0130_head.
- NP869501.RAOsv8x0wsnv79N48g0SZNgPnjY-KX3QsaEyg2TcszTw0130_assertion wasGeneratedBy ECO_0000203 NP869501.RAOsv8x0wsnv79N48g0SZNgPnjY-KX3QsaEyg2TcszTw0130_provenance.
- NP869501.RAOsv8x0wsnv79N48g0SZNgPnjY-KX3QsaEyg2TcszTw0130_assertion wasDerivedFrom befree-20140225 NP869501.RAOsv8x0wsnv79N48g0SZNgPnjY-KX3QsaEyg2TcszTw0130_provenance.
- NP869501.RAOsv8x0wsnv79N48g0SZNgPnjY-KX3QsaEyg2TcszTw0130_assertion SIO_000772 12124336 NP869501.RAOsv8x0wsnv79N48g0SZNgPnjY-KX3QsaEyg2TcszTw0130_provenance.
- NP869501.RAOsv8x0wsnv79N48g0SZNgPnjY-KX3QsaEyg2TcszTw0130_assertion evidence source_evidence_literature NP869501.RAOsv8x0wsnv79N48g0SZNgPnjY-KX3QsaEyg2TcszTw0130_provenance.
- NP869501.RAOsv8x0wsnv79N48g0SZNgPnjY-KX3QsaEyg2TcszTw0130_assertion description "[This novel combination strategy holds promise for the treatment of head and neck cancer, and the mechanism of NKG2D in activating natural killer and CTL receptors provides a foundation for additional investigation, and development of immune modulation and chemotherapy regimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869501.RAOsv8x0wsnv79N48g0SZNgPnjY-KX3QsaEyg2TcszTw0130_provenance.